Figure 8 shows that MMF treatment attenuated lymphocyte infiltration and prevented the progression of albuminuria, α-SMA infiltration, and collagen-1 deposition, while glomerulosclerosis was attenuated at the early stages of the nephropathy. The gene discussed is ACTA1; the disease is glomerulosclerosis.